Dual Association of β-Carotene With Risk of Tobacco-Related Cancers in a Cohort of French Women
Open Access
- 21 September 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 97 (18), 1338-1344
- https://doi.org/10.1093/jnci/dji276
Abstract
Background: Intervention studies have demonstrated that, in smokers, β-carotene supplements had a deleterious effect on risk of lung cancer and may have a deleterious effect on digestive cancers as well. We investigated a potential interaction between β-carotene intake and smoking on the risk of tobacco-related cancers in women. Methods: A total of 59 910 women from the French Etude Epidémiologique de Femmes de la Mutuelle Générale de l'Education Nationale (E3N) prospective investigation were studied from 1994. After a median follow-up of 7.4 years, 700 women had developed cancers known to be associated with smoking. Diet, supplement use, and smoking status at baseline were assessed by self-report. β-carotene intake was classified into four groups: first (low intake), second, and third tertiles of dietary intake, and use of supplements (high intake). Unadjusted and multivariable Cox proportional hazards models were used to calculate hazard ratios and 95% confidence intervals (CIs) for cancer risk. All statistical tests were two-sided. Results: Among never smokers, multivariable hazard ratios of all smoking-related cancers were 0.72 (95% CI = 0.57 to 0.92), 0.80 (95% CI = 0.64 to 1.01), and 0.44 (95% CI = 0.18 to 1.07) for the second and third tertiles of dietary intake, and high β-carotene intake, respectively, compared with low intake ( Ptrend = .03). Among ever smokers, multivariable hazard ratios were 1.43 (95% CI = 1.05 to 1.96), 1.20 (95% CI = 0.86 to 1.67), and 2.14 (95% CI = 1.16 to 3.97) for the second and third tertiles of dietary intake, and high β-carotene intake, respectively, compared with low intake ( Ptrend = .09). Tests for interaction between β-carotene intake and smoking were statistically significant ( Ptrend =.017). In this population, the absolute rates over 10 years in those with low and high β-carotene intake were 181.8 and 81.7 cases per 10 000 women in never smokers and 174.0 and 368.3 cases per 10 000 women in ever smokers. Conclusions: β-carotene intake was inversely associated with risk of tobacco-related cancers among nonsmokers with a statistically significant dose-dependent relationship, whereas high β-carotene intake was directly associated with risk among smokers.Keywords
This publication has 39 references indexed in Scilit:
- The SU.VI.MAX StudyArchives of Internal Medicine, 2004
- Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysisThe Lancet, 2004
- -Carotene exacerbates DNA oxidative damage and modifies p53-related pathways of cell proliferation and apoptosis in cultured cells exposed to tobacco smoke condensateCarcinogenesis: Integrative Cancer Research, 2004
- Dietary carotenoids and risk of colon cancer: Case‐control studyInternational Journal of Cancer, 2004
- β-Carotene: a cancer chemopreventive agent or a co-carcinogen?Mutation Research, 2003
- European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collectionPublic Health Nutrition, 2002
- Use of dietary supplements in Denmark is associated with health and former smokingPublic Health Nutrition, 2002
- E3N, a French cohort study on cancer risk factorsEuropean Journal Of Cancer Prevention, 1997
- Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Estimation of food portion size using photographs: validity, strengths, weaknesses and recommendationsJournal of Human Nutrition and Dietetics, 1995